Innovent

Innovent Biologics (信达生物制药) is a biopharmaceutical company founded in 2011 and headquartered in the Suzhou Industrial Park, China, that discovers, develops, manufactures, and commercializes high-quality biologic medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, and ophthalmology diseases. Its portfolio includes the PD-1 inhibitor Tyvyt (sintilimab), developed in partnership with Eli Lilly, alongside a broad pipeline of monoclonal antibodies and other biologics. Innovent is listed on the Hong Kong Stock Exchange (01801.HK) and was surfaced through the Hongshan (formerly Sequoia Capital China) portfolio. Innovent is a therapeutics company and does not publish a public developer API surface; this profile captures its corporate and domain-security identity in the API Evangelist network.

Innovent is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Biotechnology, Pharmaceuticals, and Biologics.

🌐 Visit website 📡 Source on GitHub

7.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyHealthcareBiotechnologyPharmaceuticalsBiologicsOncologyLife Sciences

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 7.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/innovent: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Company 1

The organization behind the API

Website

Website

Source (apis.yml)

aid: innovent
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/innovent.png
name: Innovent
description: Innovent Biologics (信达生物制药) is a biopharmaceutical company founded in 2011 and headquartered in the Suzhou Industrial
  Park, China, that discovers, develops, manufactures, and commercializes high-quality biologic medicines for the treatment
  of oncology, autoimmune, cardiovascular and metabolic, and ophthalmology diseases. Its portfolio includes the PD-1 inhibitor
  Tyvyt (sintilimab), developed in partnership with Eli Lilly, alongside a broad pipeline of monoclonal antibodies and other
  biologics. Innovent is listed on the Hong Kong Stock Exchange (01801.HK) and was surfaced through the Hongshan (formerly
  Sequoia Capital China) portfolio. Innovent is a therapeutics company and does not publish a public developer API surface;
  this profile captures its corporate and domain-security identity in the API Evangelist network.
url: https://raw.githubusercontent.com/api-evangelist/innovent/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- hongshan
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Healthcare
- Biotechnology
- Pharmaceuticals
- Biologics
- Oncology
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/innovent-domain-security.yml
- type: Website
  url: https://innoventbio.com
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence

Innovent

Kin Score

Security Posture 1

Innovent Domain Security

Resources

Access & Security 1

Company 1

Source (apis.yml)